Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe

BiomX Inc., through its subsidiary Zorronet Ltd., has entered into two strategic collaborations with Samura s.r.o. to deploy AI-powered monitoring solutions in Central and Eastern Europe. These collaborations target smart pest management in agriculture and the protection of critical transportation infrastructure, leveraging AI to improve efficiency…

CN Declares Third-Quarter 2026 Dividend

CN Declares Third-Quarter 2026 Dividend

Canadian National Railway (CN) announced its Board of Directors has approved a quarterly dividend of C$0.9150 per common share, payable on September 29, 2026, to shareholders of record as of September 8, 2026. CN continues to power the economy by safely transporting over 300 million tons of goods annually across its extensive North American rail ne…

Dyadic Announces Continued Listing on the Nasdaq Capital Market

Dyadic Announces Continued Listing on the Nasdaq Capital Market

Dyadic International, Inc., a biotechnology company specializing in recombinant protein production platforms, announced that it has regained compliance with Nasdaq listing requirements, ensuring its common stock continues to be listed on the Nasdaq Capital Market. The company plans to focus on executing its business strategy, including the commerci…

Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union

Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union

Zevra Therapeutics announced the Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion on the Marketing Authorization Application (MAA) for arimoclomol to treat Niemann-Pick disease type C in the European Union. The company plans to request a re-examination of the decision while continuing to provide access to the drug thr…

Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

Radiopharm Theranostics Limited announces a concurrent securities offering including a $4.1 million registered direct offering of ADSs in the US, an AUD 6.7 million Australian private placement (subject to shareholder approval), and a share purchase plan to raise an additional AUD 6 million. The company plans to use the proceeds to support the comm…

Noodles & Company Announces Second Quarter 2026 Financial Results

Noodles & Company Announces Second Quarter 2026 Financial Results

Noodles & Company reported a slight revenue increase to $127 million in Q2 2026 with robust system-wide comparable restaurant sales growth of 10.3%. The company narrowed its net loss significantly and improved operating margins and adjusted EBITDA by nearly 80%. Encouraged by these results, management has raised its full-year 2026 revenue, margin, …

Glass Lewis Joins ISS in Supporting XFLT's Proposal to Approve the King Street Sub-Advisory Agreement Ahead of Special Meeting

Glass Lewis Joins ISS in Supporting XFLT's Proposal to Approve the King Street Sub-Advisory Agreement Ahead of Special Meeting

Leading proxy advisory firms Glass Lewis and ISS have recommended that shareholders of XAI Floating Rate & Alternative Income Trust (XFLT) vote in favor of approving King Street Capital Management's Rockford Tower Asset Management as the Fund's new investment sub-adviser. This recommendation comes amid concerns over the prior sub-adviser Octagon's …

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Second Quarter Ended June 30, 2026 Financial Results

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Second Quarter Ended June 30, 2026 Financial Results

Crescent Capital BDC, Inc. (NASDAQ: CCAP) will release its financial results for the second quarter ended June 30, 2026, on August 10, 2026 after market close. The company will host a webcast and conference call on August 11 to discuss these results. Crescent Capital BDC is a US-listed business development company providing capital to middle market…

Bullish announces Siris to acquire non-core Equiniti business lines

Bullish announces Siris to acquire non-core Equiniti business lines

Bullish announced that Siris has exercised its option to acquire non-core business lines of Equiniti, streamlining the acquisition ahead of Bullish's planned purchase of Equiniti in January 2027. The transaction has secured essential competition law clearances in the UK, US, and Germany, marking significant regulatory progress. This move integrates…

MannKind Announces $50 Million Private Placement

MannKind Announces $50 Million Private Placement

MannKind Corporation announced a private placement of approximately $50 million through the sale of common stock and pre-funded warrants to institutional investors. The proceeds will be used for general corporate purposes, including funding a $45 million contingent value rights payment related to FDA approval of Furoscix ReadyFlow. The transaction …

MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease

MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease

MannKind Corporation announced FDA approval of Furoscix ReadyFlow, the first autoinjector delivering IV-equivalent subcutaneous furosemide for treating edema in adults with heart failure or chronic kidney disease. The device offers a rapid, simple way to manage fluid overload outside hospital settings, potentially reducing emergency visits and hosp…

Nova Minerals Highlights Strategic Alignment with U.S. Defense Supply Chain Priorities Under White House Executive Order

Nova Minerals Highlights Strategic Alignment with U.S. Defense Supply Chain Priorities Under White House Executive Order

Nova Minerals Corp, listed on NYSE American and ASX, welcomes the recent U.S. Executive Order promoting secure domestic critical minerals supply chains for defense. The company is developing a fully integrated U.S. antimony supply chain, supported by a $43.4 million Defense Production Act award, with pilot production targeted in 2027. This strategi…

DHT Holdings, Inc. Announces Fleet Update

DHT Holdings, Inc. Announces Fleet Update

DHT Holdings, Inc. announced the delivery of the DHT Impala, the fourth and final VLCC newbuilding from Hyundai Samho Heavy Industries for 2026, finalizing its fleet renewal program. The new vessel will enter the spot market, enhancing the fleet's efficiency and long-term earnings capacity. Concurrently, the company sold an older vessel, DHT Bauhin…